PubMed Journals Articles About "Advanced Imaging Oncology Webinar Hosted Xtalks" RSS

20:07 EST 17th January 2019 | BioPortfolio

Advanced Imaging Oncology Webinar Hosted Xtalks PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Advanced Imaging Oncology Webinar Hosted Xtalks articles that have been published worldwide.

More Information about "Advanced Imaging Oncology Webinar Hosted Xtalks" on BioPortfolio

We have published hundreds of Advanced Imaging Oncology Webinar Hosted Xtalks news stories on BioPortfolio along with dozens of Advanced Imaging Oncology Webinar Hosted Xtalks Clinical Trials and PubMed Articles about Advanced Imaging Oncology Webinar Hosted Xtalks for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Imaging Oncology Webinar Hosted Xtalks Companies in our database. You can also find out about relevant Advanced Imaging Oncology Webinar Hosted Xtalks Drugs and Medications on this site too.

Showing "Advanced Imaging Oncology Webinar Hosted Xtalks" PubMed Articles 1–25 of 14,000+

Learners' acceptance of a webinar for continuing medical education.

The aim of this study was to evaluate learners' acceptance of a webinar for continuing medical education that was instigated by the International Association of Oral and Maxillofacial Surgeons (IAOMS). A live, interactive webinar on orthognathic surgery was broadcast via the Internet. The learners' acceptance of the webinar was evaluated using a standardized, validated questionnaire (Student Evaluation of Educational Quality, SEEQ). One hundred and fifty-three participants attended the webinar; 55 participa...

Machine Learning and Imaging Informatics in Oncology.

In the era of personalized and precision medicine, informatics technologies utilizing machine learning (ML) and quantitative imaging are witnessing a rapidly increasing role in medicine in general and in oncology in particular. This expanding role ranges from computer-aided diagnosis to decision support of treatments with the potential to transform the current landscape of cancer management. In this review, we aim to provide an overview of ML methodologies and imaging informatics techniques and their recent...

New intraoperative imaging technologies: Innovating the surgeon's eye toward surgical precision.

Imaging is one of the pillars for the ongoing evolution of surgical oncology toward a precision paradigm. In the present overview, some established or emerging intraoperative imaging technologies are described in light of the vision and experience of our group in image-guided surgery, focusing on digestive surgical oncology.

Systemic therapy in advanced thymic epithelial tumors: Insights from the RYTHMIC prospective cohort.

Thymic epithelial tumors (TET) are rare malignancies that may be aggressive and difficult to treat. In the advanced setting, systemic treatments may be delivered as primary therapy before surgery or definitive radiotherapy, as exclusive treatment when no focal treatment is feasible, or in the setting of recurrences. RYTHMIC is the nationwide network for TET in France. The objective of the study was to describe the modalities and analyze the efficacy of systemic treatments for patients with advanced TET incl...

Ex vivo indocyanine green fluorescence imaging for the detection of lymph node involvement in advanced-stage ovarian cancer.

The aim of this study was to evaluate the role of indocyanine green (ICG) fluorescence imaging (FI) for the ex vivo detection of metastatic lymph nodes (LNs) in advanced stage ovarian cancer (AOC).

Imaging Advances in the Management of Kidney Cancer.

New developments in cross-sectional imaging, including contrast-enhanced ultrasound, dual-energy computed tomography, multiparametric magnetic resonance imaging, single-photon emission computed tomography, and positron emission tomography, together with novel application of existing and novel radiotracers, have changed the landscape of renal mass characterization (ie, virtual biopsy) as well as the detection of metastatic disease, prognostication, and response assessment in patients with advanced kidney can...

Imaging and diagnostic advances for intracranial meningiomas.

The archetypal imaging characteristics of meningiomas are among the most stereotypic of all central nervous system (CNS) tumors. In the era of plain film and ventriculography, imaging was only performed if a mass was suspected, and their results were more suggestive than definitive. Following more than a century of technological development, we can now rely on imaging to non-invasively diagnose meningioma with great confidence and precisely delineate the locations of these tumors relative to their surroundi...

Current perspectives in conventional and advanced imaging of the distal radioulnar joint dysfunction: review for the musculoskeletal radiologist.

Distal radioulnar joint (DRUJ) dysfunction is a common cause of ulnar sided wrist pain. Physical examination yields only subtle clues towards the underlying etiology. Thus, imaging is commonly obtained towards an improved characterization of DRUJ pathology, especially multimodality imaging, which is frequently resorted to arrive at an accurate diagnosis. With increasing use of advanced MRI and CT techniques, DRUJ imaging has become an important part of a musculoskeletal radiologist's practice. This article ...

Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma.

Objective responses are reported in 34% to 37% of patients with programmed death-1 (PD-1)-naïve advanced melanoma treated with PD-1 inhibitors. Pre-existing CD8+ T-cell infiltrate and interferon (IFN) gene signature correlate with response to PD-1 blockade. Here, we report a phase Ib/II study of pembrolizumab/pegylated (PEG)-IFN combination in PD-1-naïve advanced melanoma.

Delivery of gynecologic oncology care: Optimizing scope of advanced practice providers to enhance patient care: A Society of Gynecologic Oncology Position Paper.

HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4).

KRAS mutations in ctDNA: a promising new biomarker in advanced pancreatic cancer.

Is front line checkpoint blockade ATTRACTIVE in advanced gastric cancer?

Precision oncology in the era of radiogenomics: the case of D-2HG as an imaging biomarker for mutant IDH gliomas.

Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines.

Imaging Collateral Ventilation in Patients With Advanced Chronic Obstructive Pulmonary Disease: Relative Sensitivity of He and Xe MRI.

3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018.

Relationship between complications and long-term prognosis after total gastrectomy with splenectomy for proximal advanced gastric cancer.

FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.

This study aimed to determine the positive predictive value (PPV) of positron emission tomography/computed tomography (PET/CT) with an F-fluoro-2-deoxy-D-glucose (FDG)-avid presacral lesion for locally recurrent rectal cancer, and the additional value of magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI).

LBA-007FOLFOX/Bevacizumab +/- Irinotecan in advanced colorectal cancer (AIO) "CHARTA": Final results and multivariate prognostic factor analysis.

LBA-009KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer.

F-FDG and C-4DST PET/CT for evaluating response to platinum-based doublet chemotherapy in advanced non-small cell lung cancer: a prospective study.

4'-[Methyl-C] thiothymidine (4DST) PET/CT provides DNA synthesis imaging, which represented a higher correlation with the proliferation in advanced non-small cell lung cancer (NSCLC) than that from imaging with FDG. The aim of this prospective study was to evaluate the potential of 4DST in early therapy monitoring for advanced NSCLC, and to compare the results with those from CT and FDG PET/CT.

Evolving Systemic Treatment Landscape for Patients With Advanced Renal Cell Carcinoma.

To outline current practices and challenges in the systemic management of patients with advanced renal cell carcinoma (RCC).

Behind closed doors: How advanced cancer couples communicate at home.

Describe communication between patients with advanced cancer and their spouse/partner caregivers.

Neuroimaging of brain trauma.

The purpose of this review is to provide an update on advanced neuroimaging techniques in traumatic brain injury (TBI). We will focus this review on recent literature published within the last 18 months and the advanced neuroimaging techniques of perfusion imaging and diffusion tensor imaging (DTI).

Quick Search